'Controlled clinical trials' diaporamas de présentation

Topics in Clinical Trials (1) - 2012

Topics in Clinical Trials (1) - 2012. J. Jack Lee, Ph.D. Department of Biostatistics University of Texas M. D. Anderson Cancer Center. 1: Introduction to Clinical Trials. Why do we need them? What is a clinical trial? History of clinical trials Clinical trial phases

1.12k views • 54 slides

Averion, Inc. Presentation Data Monitoring Committee (DMC) Establishment and Management

Averion, Inc. Presentation Data Monitoring Committee (DMC) Establishment and Management. April 14, 2005. Overview Of Presentation. The Current Environment Challenges/Problems in DMC implementation Need for an external DMC Specific Tasks for DMC? Sponsors demands in a DMC

684 views • 45 slides

Systematic Reviews

Systematic Reviews. Effective Literature Searching. Brenda Thomas Information Specialist Cochrane Stroke Group. Stroke Review Group. Comprehensive and versatile register of randomised controlled trials (RCTs) and controlled clinical trials (CCTs).

529 views • 34 slides

Bios 101 Lecture 3: Experimental Designs

Bios 101 Lecture 3: Experimental Designs. Shankar Viswanathan, DrPH . Division of Biostatistics Department of Epidemiology and Population Health Albert Einstein College of Medicine, NY October 11, 2011. Analytical Studies has comparison group. Grimes et al. Lancet 2002;359:57-61.

606 views • 32 slides

Early Stopping Rules: Interim Analyses

Clinical Trials in 20 Hours. Early Stopping Rules: Interim Analyses. Elizabeth S. Garrett esg@jhu.edu Oncology Biostatistics May 8, 2002. References.

885 views • 31 slides

Drug and Drug Products Quality & Testing

King Saud University College of Pharmacy Department of Pharmaceutics PHT 463: Quality Control of Pharmaceutical Dosage Forms Summer Semester of 1423-1424H. Drug and Drug Products Quality & Testing. Ibrahim A. Alsarra, Ph.D. Outlines. Drug and Drug Products Selection

345 views • 31 slides

Chenxiong (Charles) Le, Ph.D. OBI/OB/OPaSS/CDER, FDA Cardiovascular and Renal Drugs

508 views • 27 slides

Tutorial

196 views • 9 slides

Articulating the Unmet Need in the Diagnosis and Treatment of Pseudobulbar Affect:

Articulating the Unmet Need in the Diagnosis and Treatment of Pseudobulbar Affect: Prevalence of the Condition and Limitations of Existing Therapies. Ursula Hess, PhD Torre Lazur McCann West. Estimated US Patients With PBA: 1.7 Million. No QOL studies

291 views • 8 slides